Search Results - "Janas, Mette"

Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial by Khorana, Alok A, Kamphuisen, Pieter W, Meyer, Guy, Bauersachs, Rupert, Janas, Mette S, Jarner, Mikala F, Lee, Agnes Y Y

“…Purpose Circulating tissue factor (TF) has been studied as a biomarker for predicting initial, but not recurrent, venous thromboembolism (VTE) in cancer, a…”
Get full text

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients by Lee, Agnes Y Y, Bauersachs, Rupert, Janas, Mette S, Jarner, Mikala F, Kamphuisen, Pieter W, Meyer, Guy, Khorana, Alok A

“…Low-molecular-weight heparin (LMWH) is recommended and commonly used for extended treatment of cancer-associated thrombosis (CAT), but its superiority over…”
Get full text

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial by Lee, Agnes Y. Y, Kamphuisen, Pieter W, Meyer, Guy, Bauersachs, Rupert, Janas, Mette S, Jarner, Mikala F, Khorana, Alok A

“…IMPORTANCE: Low-molecular-weight heparin is recommended over warfarin for the treatment of acute venous thromboembolism (VTE) in patients with active cancer…”
Get full text

Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep® in Renal Insufficiency Study (IRIS) by Leizorovicz, Alain, Siguret, Virginie, Mottier, Dominique

“…Abstract Introduction Trials comparing the use of full dose unfractionated heparin (UFH) or low molecular weight heparins (LMWHs) in very elderly patients with…”
Get full text

Reply to R. Fonseca et al by Khorana, Alok A, Janas, Mette, Jarner, Mikala F, Lee, Agnes Y Y

Get full text

Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: The CATCH study by Khorana, Alok A., Bauersachs, Rupert, Kamphuisen, Pieter W, Meyer, Guy, Janas, Mette S., Jarner, Mikala F., Lee, Agnes Y.

“…Abstract only…”
Get full text

A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study by Lee, Agnes Y.Y., Kamphuisen, Pieter W., Meyer, Guy, Bauersachs, Rupert, Janas, Mette S., Jarner, Mikala F, Khorana, Alok A.

“…Background Patients with cancer and VTE have a substantial risk of recurrent VTE. LMWH reduces the risk of symptomatic, recurrent VTE compared with warfarin…”
Get full text

CATCH: A randomized trial comparing tinzaparin versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients by Lee, Agnes Y., Bauersachs, Rupert, Janas, Mette S., Jarner, Mikala F., Kamphuisen, Pieter W, Meyer, Guy, Paz-Ares, Luis, Khorana, Alok A.

“…Abstract only TPS9149^ Background: VTE is a major cause of morbidity and mortality in cancer patients. LMWHs have been shown to be superior to warfarin in one…”
Get full text

An immunocytochemical study of the innervation of developing human fetal teeth using protein gene product 9.5 (PGP 9.5) by Christensen, L R, Janas, M S, Møllgård, K, Kjaer, I

“…Developing teeth of 32 human fetuses (crown-rump length 11-205 mm) were examined immunohistochemically by antisera to protein gene product 9.5 (PGP 9.5) in an…”
Get more information

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy by Giaccone, Giuseppe, Iacona, Renee B., Fandi, Abderrahim, Janas, Mette, Ochs, Judith S., Herbst, Roy S., Johnson, David H.

“…Purpose Two large, randomized, placebo-controlled trials (IRESSA NSCLC Trial Assessing Combination Therapy; INTACT 1 and 2) in non-small-cell lung cancer…”
Get full text

P-616 EGFR expression in non-small-cell lung cancer: interobserver reproducibility of visually interpreted EGFR immunohistochemical staining by Janas, Mette, Franklin, Wilbur, Schmidt, Karsten, Bailey, Renee

Get full text

Getting to grips with gefitinib by Renee Bailey, Lisa, Janas, Mette

Get more information

O-242 Gefitinib (‘Iressa’, ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer in IDEAL 1 and 2: tumor response is not clinically relevantly predictable from tumor EGFR membrane staining alone by Bailey, Renee, Kris, Mark, Wolf, Michael, Kay, Andrea, Averbuch, Steven, Askaa, Jon, Janas, Mette, Schmidt, Karsten, Fukuoka, Masahiro

Get full text

Lung hypoplasia – a possible teratogenic effect of valproate by JANAS, METTE STAGAARD, ARRØE, METTE, HANSEN, STEEN HOLGER, GRÆM, NIELS

“…Three cases of lung hypoplasia occurring in two siblings and in an unrelated child are reported. All three cases had been exposed to valproate in utero. The…”
Get full text

Lung hypoplasia - a possible teratogenic effect of valproate by JANAS, METTE STAGAARD, ARRØE, METTE, HANSEN, STEEN HOLGER, GRÆM, NIELS

Get full text

Glial cell differentiation in neuron-free and neuron-rich regions. II. Early appearance of S-100 protein positive astrocytes in human fetal hippocampus by Stagaard Janas, M, Nowakowski, R S, Møllgård, K

“…The development of the human fetal hippocampus and dentate gyrus has been studied immunocytochemically. The first glial cells to appear are vimentin-positive…”
Get more information

Immunocytochemical demonstration of nerve growth factor receptor (NGF-R) in developing human fetal teeth by Christensen, L R, Møllgård, K, Kjaer, I, Janas, M S

“…Evidence is accumulating that nerve growth factor receptor (NGF-R or p75NGFR) can mediate cell growth and differentiation of non-neuronal cells. NGF-R…”
Get more information

Glial cell differentiation in neuron-free and neuron-rich regions. I. Selective appearance of S-100 protein in radial glial cells of the hippocampal fimbria in human fetuses by Stagaard Janas, M, Nowakowski, R S, Terkelsen, O B, Møllgård, K

“…The proliferative cells of the developing hippocampal fiber tract fimbria have only the potential for gliogenesis; thus the developing fimbria provides an…”
Get more information